A proof‐of‐concept, phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide‐releasing anti‐inflammatory drug
John L. Wallace Peter Nagy; Troy D Feener; Thibault Allain; Tamás Ditrói; David J Vaughan; Marcelo Nicolás Muscará; Gilberto De Nucci; Andre G Buret
British Journal of Pharmacology Oxford V. 177, n.4, p. 769-777, 2020Oxford 2020
Item não circula. Consulte sua biblioteca.(Acessar)